PTAB challenges

The initial search results for "US5978773 PTAB", "US5978773 IPR", "US5978773 PGR", and "US5978773 CBM" did not return any relevant PTAB proceeding information for patent US5978773. The results primarily pertain to the stock ticker "PGR" (Progressive Corp) and not to patent proceedings. This confirms the statement in the prompt that the USPTO ODP API returns no AIA trial proceedings for this patent.

Therefore, I will state that there is no PTAB activity on file and provide the strategic summary and recommended next steps based on this finding.## PTAB proceedings on file

The USPTO ODP API returns no AIA trial proceedings for this patent as of the most recent ingest. A web search for Inter Partes Review (IPR), Post-Grant Review (PGR), and Covered Business Method (CBM) proceedings for US5978773 did not yield any results.

Proceedings overview

There are no recorded AIA trial proceedings (IPR, PGR, CBM) found for US Patent No. 5,978,773. This means that all claims of the patent remain untested by the PTAB.

Strategic summary

As of the current date, US Patent No. 5,978,773 has not been subjected to any AIA trial proceedings before the Patent Trial and Appeal Board (PTAB). This implies that all 41 claims of the patent, including the independent claims 1, 12, 22, 33, 35, and 36, remain in their originally granted form and have not been challenged or narrowed through IPR, PGR, or CBM trials. Consequently, there is no estoppel landscape from PTAB proceedings that would bar future petitioners from raising prior-art grounds against this patent. All potential prior-art arguments under 35 U.S.C. § 102 (novelty) and § 103 (obviousness) remain available for a defendant facing assertion of this patent.

The absence of PTAB activity is a noteworthy signal. For a patent that has been involved in multiple district court litigations, as detailed in the "Litigation summary" section, the lack of IPRs, PGRs, or CBMs might suggest several things: either the asserted claims were not considered strong candidates for PTAB challenges by defendants, the litigation settled before such challenges could be fully pursued, or the patent's effective term expired before the widespread adoption and effectiveness of AIA trials as a defensive strategy. Given the patent's expiration in October 2015, the window for instituting IPRs, PGRs, or CBMs has closed.

Recommended next steps

Since there are no PTAB proceedings on file for US Patent No. 5,978,773, a defendant currently being asserted against would not benefit from any claims having been invalidated by the PTAB. However, the patent is expired as of October 3, 2015. This means any infringement claims would pertain only to activities that occurred before this expiration date.

For a defendant facing assertion of this patent:

• Focus on Patent Expiration: The primary defense should leverage the patent's expired status. Any alleged infringement must have occurred prior to October 3, 2015.
• Prior Art Review: Since the claims were never challenged at the PTAB, the extensive prior art identified in the "Prior art" and "Obviousness" sections (e.g., U.S. Patent No. 5,305,195 and European Patent Application EP0565293A2) remains a strong basis for an invalidity defense in district court, particularly if the alleged infringement predates the patent's expiration. These arguments for lack of novelty or obviousness were never adjudicated by the PTAB.
• Damages Limited to Pre-Expiration Activity: Any potential damages would be limited to infringing acts that occurred between the issue date (November 2, 1999) and the expiration date (October 3, 2015).